home
HOME 

  WELCOME
 
The Mount Sinai Community Clinical Oncology Program (MSCCOP) is a nonprofit community-based program committed to providing novel clinical research to cancer treatment patients and to healthy individuals who may be at risk for cancer.

CCOP is a comprehensive organized clinical trials mechanism for disseminating the latest cancer prevention and treatment research findings to the community level. The aim of the program is to provide cancer patients with access to NCI-sponsored cancer treatment trials and up to date cancer management in patients’ own communities. The program increases the number of patients and physicians who can participate in clinical trials operated at major research centers, and allows scientists to conduct large-scale cancer prevention and control studies. read more ...

 
Newest Protocols
Advanced TCC (CALGB 90601): A RANDOMIZED DOUBLE-BLINDED PHASE III STUDY COMPARING GEMCITABINE, CISPLATIN, AND BEVACIZUM...
Cat: Genitourinary (03/01/2012)
Untreated Chronic Lymphocytic Leukemia (CALGB 10404): A GENETIC RISK-STRATIFIED, RANDOMIZED PHASE II STUDY OF FOUR FLUDARABINE/ANTIBODY COMBINATI...
Cat: Leukemia/MDS (02/20/2012)
Unresectable Locally Advance or Stage IV (ECOG E2607): DASATINIB IN PATIENTS WITH UNRESECTABLE LOCALLY ADVANCED OR STAGE IV MUCOSAL, ACRAL AND VUL...
Cat: Melanoma (12/22/2011)
Latest Announcements
CALGB 40601 (Closed to Accrual)
BMS CA184043 (Closed to Accrual)
CALGB 80405 (Closed to Accrual)
more ...
 



©2004 MSCCOP & Mount Sinai Medical Center